Rocky Mountain Clinical Research, LLC (RMCR)

What Rocky Mountain Clinical Research, LLC (RMCR) does

Rocky Mountain Clinical Research, LLC (RMCR) is a private, single-site clinical research organization headquartered in Idaho Falls, Idaho, founded in 2004 and operating as part of the Rocky Mountain Diabetes Center family of businesses. The company conducts Phase II-IV clinical trials for pharmaceutical, biotechnology, and medical-device sponsors, with therapeutic specialization in Type 1 diabetes, Type 2 diabetes, pediatric endocrinology (including growth disorders), and adjacent cardiometabolic indications. RMCR holds Magi Blue Ribbon Site and Site Council Charter Member designations, placing it in the top 1% of US research facilities, and operates an ACRP Membership Site with 10+ CCRC/CCRP-certified coordinators and a 130-year combined research staff experience base.

The company's service offering covers the full site-management stack: principal investigator oversight by board-certified endocrinologists and a pediatric endocrinologist medical director, regulatory document preparation, patient recruitment leveraging the parent diabetes center's patient database, and trial execution supported by an on-site full-service laboratory (Express Lab), a DEXA scanner, an ambient/-20°F/-80°F investigational product storage suite, and Florence eBinders for sponsor and CRO monitoring. Notable active or recent studies include the Insulet EVOLVE closed-loop Omnipod trial, the Ascendis HighLiGHts pediatric growth study, the Sanofi FABULINUS new-onset T1D study, the Provention Bio Beta Preserve teplizumab trial, the Novo Nordisk once-weekly insulin icodec trial, and the Boehringer Ingelheim/Eli Lilly EASi PROTKT cardiovascular outcomes trial.

RMCR's revenue model is professional-services based: sponsors pay per study/per patient for site management services, while patients participate at no cost with the sponsor covering study product, testing, and often travel reimbursement. The go-to-market motion blends direct enterprise outreach to sponsors and CROs with community-led patient recruitment through healthcare provider referrals, the established patient database, and website-driven inquiries. RMCR serves 100+ pharmaceutical and device sponsors, including Eli Lilly, Novo Nordisk, Sanofi, Insulet, Medtronic, DexCom, Abbott, Janssen, Boehringer Ingelheim, and major CROs (IQVIA, Parexel, PRA Health Sciences). No public revenue, venture funding, or M&A activity is disclosed.

Name

Rocky Mountain Clinical Research, LLC (RMCR)

Legal name

Rocky Mountain Clinical Research, LLC

Website

https://rockymountainclinicalresearch.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Rocky Mountain Clinical Research is a private, Idaho Falls-based clinical trial site specializing in diabetes, endocrinology, and pediatric studies, serving pharmaceutical and device sponsors with full-service Phase II-IV site management, on-site lab, and certified coordinators.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ), Clinical Research & Trial Central Laboratories (HLAFAMAL), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Clinical research services
• Clinical trial management
• Diabetes clinical trials
• Endocrinology research
• Medical device studies

Headquarters

HQ city

Idaho Falls

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Services: RMCR generates revenue by conducting clinical trials for pharmaceutical sponsors and CROs. They provide comprehensive site services including protocol consultation, regulatory oversight, data management, and patient recruitment for clinical studies in diabetes and other therapeutic areas.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Rocky Mountain Clinical Research operates a dedicated clinical research site in Idaho Falls, Idaho, conducting Phase II–IV clinical trials for pharmaceutical sponsors and CROs with a focus on diabetes (Type 1, Type 2, pediatric), endocrinology, growth disorders, and diabetes-related medical devices. The site delivers Principal Investigator oversight, GCP-compliant trial execution, regulatory document management, on-site laboratory and investigational product storage, and electronic data capture for sponsor monitoring. Patients participate at no cost; sponsors contract directly for trial services.

Product overview

Rocky Mountain Clinical Research is a full-service clinical research site providing Phase II-IV clinical trial management for pharmaceutical and medical device sponsors. The company operates as part of the Rocky Mountain Diabetes Center family of businesses and specializes in endocrinology and diabetes-related studies. Their core offerings include conducting clinical research studies across Type 1 Diabetes, Type 2 Diabetes, Pediatric Diabetes, and Medical Devices categories, with specific named studies such as EVOLVE (Omnipod closed-loop system), HighLiGHts (pediatric growth hormone), EASi PROTKT (cardiovascular outcomes), Beta Preserve (T1D preservation), Long Acting Insulin (weekly insulin icodec), and Sanofi FABULINUS (newly diagnosed T1D). Supporting infrastructure includes on-site Express Lab for STAT and custom testing, dedicated investigational product storage (ambient, refrigerated at -20°F and -80°F), biochemical processing rooms, DEXA scanning, and dedicated sponsor/CRO monitoring facilities with Florence eBinders eTMF integration.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Studies (Type 1, Type 2, Pediatric Diabetes, Medical Devices, Other)

Quantifiable outcome

• Top 1% research facility in the United States
• +3 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Rocky Mountain Diabetes CentercoreStrategic or Co-development PartnerParent organization and integrated clinical care provider. RMCR is an integral part of the Rocky Mountain Diabetes Center family of businesses. Clinical research has been a major part of the practice for over 20 years, enabling access to well-characterized patient populations and integrated diabetes care expertise.
• Express LabcoreStrategic or Co-development PartnerOn-site full-service medical laboratory providing STAT testing, custom lab testing, and add-on testing capabilities. Located within the RMCR facility, enabling immediate access to laboratory services for clinical trial participants.
• Rocky Mountain PharmacyminorStrategic or Co-development PartnerPart of the Rocky Mountain Diabetes family of businesses providing pharmacy services that complement clinical research and diabetes care operations.
• FlorencecoreTechnology or IntegrationElectronic data capture (EDC) and site management system providing in-person and off-site monitoring capabilities. Enables sponsors and CROs to easily stay up-to-date with study oversight through eBinders technology.
• Eli Lilly and CompanycoreStrategic or Co-development PartnerMajor pharmaceutical sponsor with multiple collaborations. Mark Sulik has served on several advisory boards for Eli Lilly including Coordinators Advisory Board, Technology Advisory Board, Study Coordinator Advisory Board, Biomedicine Advisory Board, and Clinical Research Strategy & Study Design.
• T1D ExchangecoreStrategic or Co-development PartnerNonprofit research organization focused on Type 1 Diabetes. RMCR has received multiple Outstanding Performance Awards from T1D Exchange for clinical research excellence (2013, 2014, 2015).
• ACRP (Association of Clinical Research Professionals)coreStrategic or Co-development PartnerProfessional organization for clinical research professionals. RMCR is an ACRP membership site with 10+ CCRC or CCRP certified staff members. Coordinators obtain certification through ACRP.
• SOCRA (Society of Clinical Research Associates)minorStrategic or Co-development PartnerProfessional organization for clinical research professionals. Listed as a professional affiliation for Mark Sulik, Director of Clinical Research.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Fortrea: Fortrea (formerly Labcorp Drug Development) is a global CRO offering Phase I-IV clinical development services, including site management solutions. Comparable to RMCR in clinical trial execution capabilities, but operates at significantly larger scale with broader therapeutic and geographic coverage.
• IQVIA: IQVIA is the largest global CRO and operates an integrated site network (Prime Sites) offering Phase I-IV clinical research services. Comparable to RMCR as a clinical trial site operator and existing RMCR sponsor partner, but operates at vastly larger scale across all therapeutic areas and geographies.
• ICON plc: ICON plc is a global clinical research organization providing drug and device development services including site management, laboratory services, and decentralized trial capabilities. Comparable to RMCR through clinical research site services, with vastly broader therapeutic coverage and global site network footprint.
• Syneos Health: Syneos Health is a global biopharmaceutical solutions organization offering clinical development and contract commercialization services, including site network operations. Comparable to RMCR through its clinical trial site management capabilities, but at a global scale and integrated with broader CRO services.

Direct peers

• PMG Research: PMG Research is an integrated network of clinical research sites conducting Phase I-IV trials across multiple therapeutic areas. Directly comparable to RMCR as a multi-specialty SMO with similar sponsor contracting, regulatory expertise, and patient recruitment capabilities, but with broader geographic reach and larger consolidated sponsor relationships.
• Benchmark Research: Benchmark Research operates multiple clinical research sites with focus on vaccine, infectious disease, and chronic disease trials. Comparable to RMCR in its independent site network model and Phase II-IV trial execution, with similar EDC integration and certified coordinator staffing.
• Velocity Clinical Research: Velocity Clinical Research operates an integrated network of clinical research sites across the United States, providing Phase II-IV trial execution for pharmaceutical and device sponsors. Directly comparable to RMCR as an SMO with similar multi-therapeutic trial execution, EDC integration, and sponsor contracting model; differentiated primarily by multi-site scale.
• Accel Research Sites: Accel Research Sites is a multi-site clinical research network specializing in Phase II-IV trials across multiple therapeutic areas including diabetes, endocrinology, and CNS. Comparable to RMCR in its therapeutic focus on chronic disease and its SMO/site management business model, with the key difference of operating multiple geographically distributed sites.
• Quality Clinical Research: Quality Clinical Research is an independent clinical research site with a diabetes and endocrinology focus, conducting trials for pharmaceutical sponsors. Highly comparable to RMCR in therapeutic specialization, patient population access, and SMO-style operations, with similar on-site laboratory and investigator staffing models.

Others

• T1D Exchange: T1D Exchange is a nonprofit Type 1 diabetes research organization that collaborates with clinical research sites on studies including residual C-peptide and severe hypoglycemia research. Comparable to RMCR as a Type 1 diabetes research ecosystem participant and an RMCR partner, but functions as a study sponsor/convener rather than a competing site.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rocky-mountain-clinical-research-llc-rmcr

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rocky Mountain Clinical Research, LLC (RMCR)